Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
05/2014
05/14/2014EP2729475A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
05/14/2014EP2729474A1 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
05/14/2014EP2729473A1 Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring
05/14/2014EP2729472A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
05/14/2014EP2729471A1 Carboxylic acid derivatives having an oxazolo[5,4-d]pyridine ring
05/14/2014CN103797016A 作为神经元烟碱性乙酰胆碱受体配体的1,4-二氮杂双环[3.2.2]壬烷类 As neurons 1,4-diaza nicotinic acetylcholine receptor ligand bicyclic [3.2.2] nonane class
05/14/2014CN103797015A 具有噁唑并[4,5-c]吡啶环的羧酸衍生物 Carboxylic acid derivatives having oxazolo [4,5-c] pyridine ring
05/14/2014CN103797006A 用作端锚聚合酶抑制剂的4-哌啶基化合物 Used tankyrase inhibitors 4- piperidinyl compound
05/14/2014CN103788114A 一种依维莫司的制备方法 A method of preparing everolimus
05/14/2014CN103788066A 一类保护移植器官的化合物及其用途 A class of compounds to protect transplanted organs and their use
05/14/2014CN102827187B 氟喹诺酮醛缩异烟腙及其制备方法和应用 Fluoroquinolone aldolase Isonicotinic hydrazone and its preparation method and application
05/13/2014CA2647208C Glucokinase activators
05/08/2014WO2014067003A1 Glycosidase inhibitors and uses thereof
05/08/2014WO2012125926A3 Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases
05/08/2014US20140128580 Antibody-drug conjugates and methods
05/08/2014US20140128419 Rifaximin
05/08/2014US20140128382 5-substituted iminothiazines and their mono- and dioxides as bace inhibitors, compositions, and their use
05/08/2014US20140128375 Benzazepine compounds as cgrp receptor antagonists
05/08/2014US20140128371 Chemical compounds 542
05/07/2014EP2727585A1 In-vivo screening method
05/07/2014EP2726469A1 Oxazepines as ion channel modulators
05/07/2014EP2726466A1 Fused benzoxazepinones as ion channel modulators
05/07/2014CN103781792A 具有噁唑并[5,4-d]嘧啶环的羧酸衍生物 Carboxylic acid derivatives having oxazolo [5,4-d] pyrimidine ring
05/07/2014CN103781791A 具有噁唑并[4,5-c]吡啶环的羧酸衍生物 Carboxylic acid derivatives having oxazolo [4,5-c] pyridine ring
05/07/2014CN103781790A 具有噁唑并[5,4-b]吡啶环的羧酸衍生物 Carboxylic acid derivatives having oxazolo [5,4-b] pyridine ring
05/07/2014CN103781789A 用于治疗呼吸道合胞病毒感染的化合物 Compounds for the treatment of respiratory syncytial virus infection
05/07/2014CN103781785A 作为α2肾上腺素能受体的调节剂的N-(咪唑烷-2-亚基)-杂环戊并[b]吡啶衍生物 As α2 adrenergic receptor modulators N- (imidazol-2-ylidene) - heterocyclopentadienyl and [b] pyridine derivatives
05/07/2014CN103772413A 一种利福平Ⅱ晶型的制备方法 One kind of a method for preparing crystalline form Ⅱ rifampicin
05/07/2014CN103772412A 一种帕珠沙星中间体的制备方法 A method of preparing intermediates pazufloxacin
05/07/2014CN103772373A 作为受体酪氨酸激酶抑制剂的喹唑啉类似物 As receptor tyrosine kinase inhibitors quinazoline analogs
05/07/2014CN103772233A 一种含多氟烷基五元环状硝酮衍生物及其制备方法 A multi-fluoroalkyl five-membered cyclic nitrone derivatives and their preparation containing
05/07/2014CN102159582B 作为Edg-1受体激动剂的噁唑并嘧啶 Edg-1 receptor agonists as oxazole pyrimidine
05/07/2014CN101516850B 适用作e1活化酶抑制剂的杂芳基化合物 Activating enzyme inhibitors suitable for e1 heteroaryl compound
05/06/2014US8716524 Optically active quaternary ammonium salt having axial asymmetry and process for producing a-amino acid and derivative thereof with the same
05/06/2014US8716307 Combination antineoplastic therapy
05/06/2014US8716293 Macrocyclic integrase inhibitors
05/06/2014US8716280 Bicyclic antibiotics
05/06/2014US8716278 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
05/06/2014US8716277 Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity
05/06/2014US8715341 Drug-delivery endovascular stent and method of forming the same
05/01/2014WO2014066318A1 Combination therapies for the treatment of alzheimer's disease and related disorders
05/01/2014WO2014065434A1 Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
05/01/2014WO2014065270A1 Tetrahydrooxazolo-pyridine derivative
05/01/2014WO2014063778A1 2-aminopyridine compounds
05/01/2014US20140121199 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
04/2014
04/30/2014EP2723737A1 Bridged bicyclic compounds for the treatment of bacterial infections
04/30/2014CN103764652A Tricyclic pyrazole sulfonamide compounds and methods of making and using same
04/30/2014CN103755723A Method for preparing rifampicin I crystal form
04/30/2014CN103755722A Levofloxacin and ofloxacin synthesis method
04/29/2014US8710229 Hepatitis C virus inhibitors
04/29/2014US8710216 Organic compounds
04/29/2014US8710043 TRPM8 antagonists and their use in treatments
04/29/2014US8709431 Enediyne compounds, conjugates thereof, and uses and methods therefor
04/29/2014CA2791389C Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as beta - secretase modulators and their medical use
04/24/2014WO2014062636A1 Compounds for the treatment of hepatitis c
04/24/2014US20140113895 Filamin a binding anti-inflammatory and analgesic
04/24/2014US20140113882 Azaquinazoline Inhibitors of Atypical Protein Kinase C
04/23/2014EP2722333A1 Spiro-indole derivatives for the treatment of parasitic diseases.
04/23/2014EP2721025A1 New selective ccr2 antagonists
04/23/2014EP2721016A1 Trpv4 antagonists
04/23/2014CN103748094A Tricyclic sulfonamide compounds and methods of making and using same
04/23/2014CN103739617A Isoxazole norcantharidin derivative, and preparation method and application thereof
04/23/2014CN103739616A Thiazolyl-containing rapamycin type derivative and application thereof
04/23/2014CN103739615A Ketone compound with antitumor activity and application of ketone compound
04/23/2014CN102356068B 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
04/22/2014US8703951 Synthesis of 4H-benzo[D]pyrrolo[1,2-A]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic agents
04/22/2014US8703949 Tandem process for preparing N-alkyl morphinans
04/22/2014US8703796 3H-imidazo [4, 5-B] pyridine-6-carboxamides as anti-inflammatory agents
04/22/2014US8703794 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
04/22/2014US8703766 Oxadiazoanthracene compounds for the treatment of diabetes
04/22/2014US8703755 Analogs of benzoquinone-containing ansamycins and methods of use thereof
04/17/2014WO2014059422A1 Novel process for making compounds for use in the treatment of cancer
04/17/2014WO2014059185A1 Amino - dihydrothiazine and amino - dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
04/17/2014WO2014056083A1 Kinase inhibitors and method of treating cancer with same
04/17/2014US20140107110 Anti-fibrotic pyridinones
04/17/2014US20140107109 Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
04/17/2014US20140107106 Therapeutic agents, and methods of making and using the same
04/17/2014US20140107098 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
04/17/2014US20140107073 GDF-8 Inhibitors
04/17/2014US20140105895 Treatment of solid tumors with rapamycin derivatives
04/16/2014EP2719698A1 Methods for preparing aurora kinase inhibitors
04/16/2014EP2718279A1 Novel compounds as modulators of gpr-119
04/16/2014CN103732593A Quinazoline-2,4-dione derivatives
04/16/2014CN103732583A Trpv4 antagonists
04/16/2014CN103724262A Fluoroquinolonesilver compound as well as preparation method and application thereof
04/16/2014CN102617599B Macrocyclic compound and application thereof
04/16/2014CN102584836B Porphyrin cage compound, and preparation method and application thereof
04/16/2014CN102574854B Macrocyclic integrase inhibitors
04/16/2014CN102464669B Amorphous everolimus and preparation method thereof
04/16/2014CN102333773B Mineralocorticoid receptor antagonist and methods of use
04/16/2014CN102174053B Method for purifying everolimus
04/15/2014US8697911 Rho kinase inhibitors
04/15/2014US8697910 Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same
04/15/2014US8697706 Compounds for the treatment of hepatitis C
04/15/2014US8697704 Hepatitis C virus inhibitors
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
04/15/2014US8697697 Pyrazole derivatives as ERK inhibitors
04/15/2014CA2525130C Improved cytotoxic agents comprising new maytansinoids
04/10/2014WO2014055955A1 Gdf-8 inhibitors
04/10/2014WO2014055548A1 Anti-fibrotic pyridinones
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 220